Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 239

1.

Evaluation of one year of frequent dialysis on fluid load and body composition using calf bioimpedance technique.

Zhu F, Kaysen GA, Sarkar S, Finkelstein FO, Carter M, Levin NW, Hoenich NA.

Physiol Meas. 2019 Jun 4;40(5):055004. doi: 10.1088/1361-6579/ab1d8f.

PMID:
31035269
2.

The effect of increased frequency of hemodialysis on serum cystatin C and β2-microglobulin concentrations: A secondary analysis of the frequent hemodialysis network (FHN) trial.

Huang SS, Kaysen GA, Levin NW, Kliger AS, Beck GJ, Rocco MV, Filler G, Lindsay RM; Frequent Hemodialysis Network (FHN) Group.

Hemodial Int. 2019 Jul;23(3):297-305. doi: 10.1111/hdi.12749. Epub 2019 Mar 12.

PMID:
30861262
3.

Frailty Among Patients Receiving Hemodialysis: Evolution of Components and Associations With Mortality.

Johansen KL, Delgado C, Kaysen GA, Chertow GM, Chiang J, Dalrymple LS, Segal MR, Grimes BA.

J Gerontol A Biol Sci Med Sci. 2019 Feb 15;74(3):380-386. doi: 10.1093/gerona/gly206.

PMID:
30192916
4.

Low testosterone is associated with frailty, muscle wasting and physical dysfunction among men receiving hemodialysis: a longitudinal analysis.

Chiang JM, Kaysen GA, Segal M, Chertow GM, Delgado C, Johansen KL.

Nephrol Dial Transplant. 2019 May 1;34(5):802-810. doi: 10.1093/ndt/gfy252.

PMID:
30085235
5.

Lipid levels are inversely associated with infectious and all-cause mortality: international MONDO study results.

Kaysen GA, Ye X, Raimann JG, Wang Y, Topping A, Usvyat LA, Stuard S, Canaud B, van der Sande FM, Kooman JP, Kotanko P; Monitoring Dialysis Outcomes (MONDO) Initiative.

J Lipid Res. 2018 Aug;59(8):1519-1528. doi: 10.1194/jlr.P084277. Epub 2018 Jun 12.

6.

Changes in Biomarker Profile and Left Ventricular Hypertrophy Regression: Results from the Frequent Hemodialysis Network Trials.

Chan CT, Kaysen GA, Beck GJ, Li M, Lo J, Rocco MV, Kliger AS; FHN Trials.

Am J Nephrol. 2018;47(3):208-217. doi: 10.1159/000488003. Epub 2018 Apr 5.

7.

Fibroblast Growth Factor 23 is Associated With Adiposity in Patients Receiving Hemodialysis: Possible Cross Talk Between Bone and Adipose Tissue.

Chiang JM, Kaysen GA, Schafer AL, Delgado C, Johansen KL.

J Ren Nutr. 2018 Jul;28(4):278-282. doi: 10.1053/j.jrn.2017.12.010. Epub 2018 Mar 29.

8.

Associations of lipoproteins with cardiovascular and infection-related outcomes in patients receiving hemodialysis.

Kaysen GA, Grimes B, Dalrymple LS, Chertow GM, Ishida JH, Delgado C, Segal M, Chiang J, Dwyer T, Johansen KL.

J Clin Lipidol. 2018 Mar - Apr;12(2):481-487.e14. doi: 10.1016/j.jacl.2017.12.007. Epub 2017 Dec 27.

9.

Gut Endothelial Leakage of Endotoxin May Be the Source of Vascular Inflammation and Injury in CKD. How Can This Be Targeted?

Madan N, Kaysen GA.

J Ren Nutr. 2018 Jan;28(1):1-3. doi: 10.1053/j.jrn.2017.11.001. No abstract available.

PMID:
29249294
10.

Albumin handling in different hemodialysis modalities.

van Gelder MK, Abrahams AC, Joles JA, Kaysen GA, Gerritsen KGF.

Nephrol Dial Transplant. 2018 Jun 1;33(6):906-913. doi: 10.1093/ndt/gfx191.

PMID:
29106652
11.

Association between change in serum bicarbonate and change in thyroid hormone levels in patients receiving conventional or more frequent maintenance haemodialysis.

Molfino A, Beck GJ, Li M, Lo JC, Kaysen GA; FHN Investigators.

Nephrology (Carlton). 2019 Jan;24(1):81-87. doi: 10.1111/nep.13187.

PMID:
29064128
12.

Associations of Body Mass Index and Body Fat With Markers of Inflammation and Nutrition Among Patients Receiving Hemodialysis.

Delgado C, Chertow GM, Kaysen GA, Dalrymple LS, Kornak J, Grimes B, Johansen KL.

Am J Kidney Dis. 2017 Dec;70(6):817-825. doi: 10.1053/j.ajkd.2017.06.028. Epub 2017 Sep 1.

PMID:
28870376
13.

Factors Associated with Frailty and Its Trajectory among Patients on Hemodialysis.

Johansen KL, Dalrymple LS, Delgado C, Chertow GM, Segal MR, Chiang J, Grimes B, Kaysen GA.

Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1100-1108. doi: 10.2215/CJN.12131116. Epub 2017 Jun 2.

14.

Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis.

Kittiskulnam P, Chertow GM, Carrero JJ, Delgado C, Kaysen GA, Johansen KL.

Kidney Int. 2017 Jul;92(1):238-247. doi: 10.1016/j.kint.2017.01.024. Epub 2017 Mar 17.

15.

Thyroid function in end stage renal disease and effects of frequent hemodialysis.

Lo JC, Beck GJ, Kaysen GA, Chan CT, Kliger AS, Rocco MV, Li M, Chertow GM; FHN Study.

Hemodial Int. 2017 Oct;21(4):534-541. doi: 10.1111/hdi.12527. Epub 2017 Mar 16.

PMID:
28301073
16.

HDL Glycoprotein Composition and Site-Specific Glycosylation Differentiates Between Clinical Groups and Affects IL-6 Secretion in Lipopolysaccharide-Stimulated Monocytes.

Krishnan S, Shimoda M, Sacchi R, Kailemia MJ, Luxardi G, Kaysen GA, Parikh AN, Ngassam VN, Johansen K, Chertow GM, Grimes B, Smilowitz JT, Maverakis E, Lebrilla CB, Zivkovic AM.

Sci Rep. 2017 Mar 13;7:43728. doi: 10.1038/srep43728.

17.

Lipid-Lowering Therapy in CKD: Should We Use It and in Which Patients.

Kaysen GA.

Blood Purif. 2017;43(1-3):196-199. doi: 10.1159/000452727. Epub 2017 Jan 24.

18.

Sarcopenia among patients receiving hemodialysis: weighing the evidence.

Kittiskulnam P, Carrero JJ, Chertow GM, Kaysen GA, Delgado C, Johansen KL.

J Cachexia Sarcopenia Muscle. 2017 Feb;8(1):57-68. doi: 10.1002/jcsm.12130. Epub 2016 Aug 11.

19.

Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis.

Lo JC, Beck GJ, Kaysen GA, Chan CT, Kliger AS, Rocco MV, Chertow GM; FHN Study.

Hemodial Int. 2017 Apr;21(2):190-196. doi: 10.1111/hdi.12489. Epub 2016 Oct 23.

PMID:
27774730
20.

Predialysis volume overload and patient-reported sleep duration and quality in patients receiving hemodialysis.

Abreo AP, Dalrymple LS, Chertow GM, Kaysen GA, Herzog CA, Johansen KL.

Hemodial Int. 2017 Jan;21(1):133-141. doi: 10.1111/hdi.12446. Epub 2016 Jun 27.

PMID:
27346666
21.

Treatment of Hyperlipidemia Changes With Level of Kidney Function-Rationale.

Ananthakrishnan S, Kaysen GA.

Adv Chronic Kidney Dis. 2016 Jul;23(4):247-54. doi: 10.1053/j.ackd.2015.12.004. Review.

PMID:
27324678
22.

Lower C-reactive protein and better hemodialysis survival are associated with regular exercise activity: Longitudinal outcomes from the ACTIVE-ADIPOSE special study.

Kutner NG, Zhang R, Huang Y, Kaysen GA, Park J.

Hemodial Int. 2016 Jul;20(3):473-83. doi: 10.1111/hdi.12408. Epub 2016 Mar 7.

PMID:
26954723
23.

The Effect of Increased Frequency of Hemodialysis on Volume-Related Outcomes: A Secondary Analysis of the Frequent Hemodialysis Network Trials.

Raimann JG, Chan CT, Daugirdas JT, Depner T, Gotch FA, Greene T, Kaysen GA, Kliger AS, Kotanko P, Larive B, Lindsay R, Rocco MV, Chertow GM, Levin NW; Frequent Hemodialysis Network (FHN) Trial Group.

Blood Purif. 2016;41(4):277-86. doi: 10.1159/000441966. Epub 2016 Jan 21.

24.

Association of Performance-Based and Self-Reported Function-Based Definitions of Frailty with Mortality among Patients Receiving Hemodialysis.

Johansen KL, Dalrymple LS, Glidden D, Delgado C, Kaysen GA, Grimes B, Chertow GM.

Clin J Am Soc Nephrol. 2016 Apr 7;11(4):626-32. doi: 10.2215/CJN.03710415. Epub 2016 Jan 20.

25.

Misclassification of Obesity by Body Mass Index Among Patients Receiving Hemodialysis.

Kittiskulnam P, Chertow GM, Kaysen GA, Delgado C, Dalrymple LS, Johansen KL.

Am J Kidney Dis. 2016 Apr;67(4):709-11. doi: 10.1053/j.ajkd.2015.09.028. Epub 2015 Nov 21. No abstract available.

26.

Risk Factors for Infection-Related Hospitalization in In-Center Hemodialysis.

Dalrymple LS, Mu Y, Nguyen DV, Romano PS, Chertow GM, Grimes B, Kaysen GA, Johansen KL.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2170-80. doi: 10.2215/CJN.03050315. Epub 2015 Nov 13.

27.

Validating Appetite Assessment Tools Among Patients Receiving Hemodialysis.

Molfino A, Kaysen GA, Chertow GM, Doyle J, Delgado C, Dwyer T, Laviano A, Rossi Fanelli F, Johansen KL.

J Ren Nutr. 2016 Mar;26(2):103-10. doi: 10.1053/j.jrn.2015.09.002. Epub 2015 Oct 28. Erratum in: J Ren Nutr. 2017 Nov;27(6):487.

28.

Association of Self-Reported Frailty with Falls and Fractures among Patients New to Dialysis.

Delgado C, Shieh S, Grimes B, Chertow GM, Dalrymple LS, Kaysen GA, Kornak J, Johansen KL.

Am J Nephrol. 2015;42(2):134-40. doi: 10.1159/000439000. Epub 2015 Sep 19.

29.

Association of bioimpedance spectroscopy-based volume estimation with postdialysis hypotension in patients receiving hemodialysis.

Abreo AP, Chertow GM, Dalrymple LS, Kaysen GA, Johansen KL.

Hemodial Int. 2015 Oct;19(4):536-42. doi: 10.1111/hdi.12305. Epub 2015 Apr 16.

30.

Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.

Kaysen GA, Johansen KL, Chertow GM, Dalrymple LS, Kornak J, Grimes B, Dwyer T, Chassy AW, Fiehn O.

J Ren Nutr. 2015 Jul;25(4):351-6. doi: 10.1053/j.jrn.2015.02.006. Epub 2015 Mar 19.

31.

Outcomes of infection-related hospitalization in Medicare beneficiaries receiving in-center hemodialysis.

Dalrymple LS, Mu Y, Romano PS, Nguyen DV, Chertow GM, Delgado C, Grimes B, Kaysen GA, Johansen KL.

Am J Kidney Dis. 2015 May;65(5):754-62. doi: 10.1053/j.ajkd.2014.11.030. Epub 2015 Jan 30.

32.

Agreement of single- and multi-frequency bioimpedance measurements in hemodialysis patients: an ancillary study of the Frequent Hemodialysis Network Daily Trial.

Raimann JG, Abbas SR, Liu L, Zhu F, Larive B, Kotanko P, Levin NW, Kaysen GA; FHN Trial.

Nephron Clin Pract. 2014;128(1-2):115-26. doi: 10.1159/000366447. Epub 2014 Nov 7.

33.

Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.

Langefeld CD, Divers J, Pajewski NM, Hawfield AT, Reboussin DM, Bild DE, Kaysen GA, Kimmel PL, Raj DS, Ricardo AC, Wright JT Jr, Sedor JR, Rocco MV, Freedman BI; Systolic Blood Pressure Intervention Trial (SPRINT).

Kidney Int. 2015 Jan;87(1):169-75. doi: 10.1038/ki.2014.254. Epub 2014 Jul 16.

34.

Comparison of self-report-based and physical performance-based frailty definitions among patients receiving maintenance hemodialysis.

Johansen KL, Dalrymple LS, Delgado C, Kaysen GA, Kornak J, Grimes B, Chertow GM.

Am J Kidney Dis. 2014 Oct;64(4):600-7. doi: 10.1053/j.ajkd.2014.03.016. Epub 2014 Apr 30. Erratum in: Am J Kidney Dis. 2015 Jul;66(1):178.

35.

Effect of change in fluid distribution in segments in hemodialysis patients at different ultrafiltration rates on accuracy of whole body bioimpedance measurement.

Abbas SR, Zhu F, Kaysen GA, Kotanko P, Levin NW.

J Appl Physiol (1985). 2014 Jun 1;116(11):1382-9. doi: 10.1152/japplphysiol.01361.2013. Epub 2014 Mar 27.

36.

Calibration of the brief food frequency questionnaire among patients on dialysis.

Delgado C, Ward P, Chertow GM, Storer L, Dalrymple L, Block T, Kaysen GA, Kornak J, Grimes B, Kutner NG, Johansen KL.

J Ren Nutr. 2014 May;24(3):151-156.e1. doi: 10.1053/j.jrn.2013.12.004. Epub 2014 Mar 5. Erratum in: J Ren Nutr. 2015 Jul;25(4):397.

37.

Progressive inflammation and wasting in patients with ESRD.

Kaysen GA.

Clin J Am Soc Nephrol. 2014 Feb;9(2):225-6. doi: 10.2215/CJN.12541213. Epub 2014 Jan 23. No abstract available.

38.

Comparison of hospitalization rates among for-profit and nonprofit dialysis facilities.

Dalrymple LS, Johansen KL, Romano PS, Chertow GM, Mu Y, Ishida JH, Grimes B, Kaysen GA, Nguyen DV.

Clin J Am Soc Nephrol. 2014 Jan;9(1):73-81. doi: 10.2215/CJN.04200413. Epub 2013 Dec 26.

39.

If oxidative stress is an appropriate and specific target, what reagent should we choose?

Kaysen GA, Chin A.

J Am Soc Nephrol. 2014 Mar;25(3):427-9. doi: 10.1681/ASN.2013111178. Epub 2013 Dec 19. No abstract available.

40.

Association between body composition and frailty among prevalent hemodialysis patients: a US Renal Data System special study.

Johansen KL, Dalrymple LS, Delgado C, Kaysen GA, Kornak J, Grimes B, Chertow GM.

J Am Soc Nephrol. 2014 Feb;25(2):381-9. doi: 10.1681/ASN.2013040431. Epub 2013 Oct 24.

41.

Comparison of fluid volume estimates in chronic hemodialysis patients by bioimpedance, direct isotopic, and dilution methods.

Raimann JG, Zhu F, Wang J, Thijssen S, Kuhlmann MK, Kotanko P, Levin NW, Kaysen GA.

Kidney Int. 2014 Apr;85(4):898-908. doi: 10.1038/ki.2013.358. Epub 2013 Sep 25.

42.

Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysis.

Kaysen GA, Dalrymple LS, Grimes B, Chertow GM, Kornak J, Johansen KL.

Nephrol Dial Transplant. 2014 Feb;29(2):430-7. doi: 10.1093/ndt/gft370. Epub 2013 Sep 5.

43.

Vitamin D deficiency and mortality in patients receiving dialysis: the Comprehensive Dialysis Study.

Anand S, Chertow GM, Johansen KL, Grimes B, Dalrymple LS, Kaysen GA, Kurella Tamura M.

J Ren Nutr. 2013 Nov;23(6):422-7. doi: 10.1053/j.jrn.2013.05.003. Epub 2013 Jul 19.

44.

Comparison of bioimpedance and dual-energy x-ray absorptiometry for measurement of fat mass in hemodialysis patients.

Molfino A, Don BR, Kaysen GA.

Nephron Clin Pract. 2012;122(3-4):127-33. doi: 10.1159/000350817. Epub 2013 May 9.

45.

Prealbumin is associated with visceral fat mass in patients receiving hemodialysis.

Molfino A, Heymsfield SB, Zhu F, Kotanko P, Levin NW, Dwyer T, Kaysen GA.

J Ren Nutr. 2013 Nov;23(6):406-10. doi: 10.1053/j.jrn.2013.02.007. Epub 2013 Apr 24.

46.

Effect of frequent hemodialysis on residual kidney function.

Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, Chertow GM, Ornt DB, Raimann JG, Larive B, Kliger AS; FHN Trial Group.

Kidney Int. 2013 May;83(5):949-58. doi: 10.1038/ki.2012.457. Epub 2013 Jan 23.

47.

Dietary protein restriction and preservation of kidney function in chronic kidney disease.

Kaysen GA, Odabaei G.

Blood Purif. 2013;35(1-3):22-5. doi: 10.1159/000345174. Epub 2013 Jan 22. Review.

48.

Modeling time-varying effects with generalized and unsynchronized longitudinal data.

Şentürk D, Dalrymple LS, Mohammed SM, Kaysen GA, Nguyen DV.

Stat Med. 2013 Jul 30;32(17):2971-87. doi: 10.1002/sim.5740. Epub 2013 Jan 18.

49.

Association of physical activity with survival among ambulatory patients on dialysis: the Comprehensive Dialysis Study.

Johansen KL, Kaysen GA, Dalrymple LS, Grimes BA, Glidden DV, Anand S, Chertow GM.

Clin J Am Soc Nephrol. 2013 Feb;8(2):248-53. doi: 10.2215/CJN.08560812. Epub 2012 Nov 2.

50.

Physical activity and self-reported symptoms of insomnia, restless legs syndrome, and depression: the comprehensive dialysis study.

Anand S, Johansen KL, Grimes B, Kaysen GA, Dalrymple LS, Kutner NG, Chertow GM.

Hemodial Int. 2013 Jan;17(1):50-8. doi: 10.1111/j.1542-4758.2012.00726.x. Epub 2012 Jul 20.

Supplemental Content

Loading ...
Support Center